12.57  -0.97 (-7.16%)		01-16 16:00
Open: 13.45 High: 13.69 Volume: 169,661		Pre. Close: 13.54 Low: 12.55 Market Cap: 334(M)

Short term
Mid term
Targets	6-month :	15.82	1-year :	17.32
Resists	First :	13.54	Second :	14.82
Pivot price	12.97
Supports	First :	11.47	Second :	9.54
MAs	MA(5) :	13.51	MA(20) :	13.01
	MA(100) :	13.41	MA(250) :	0
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	44.2	D(3) :	58.4
RSI	RSI(14): 46.5
52-week	High :	17.19	Low :	11.47

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CARL ] has closed above bottom band by 36.5%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	13.71 - 13.77	13.77 - 13.84
Low:	12.37 - 12.44	12.44 - 12.52
Close:	12.43 - 12.55	12.55 - 12.67

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

Tue, 09 Dec 2025
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance

Sat, 29 Nov 2025
Carlsmed: Back To Where We Started - Seeking Alpha

Fri, 07 Nov 2025
Carlsmed stock price target raised to $24 by BTIG on strong Q3 results - Investing.com

Thu, 06 Nov 2025
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - Ortho Spine News

Wed, 29 Oct 2025
Carlsmed Secures $60 Million Credit Facility Amendment - MSN

Mon, 22 Sep 2025
AI-Powered Spine Surgery Innovator Carlsmed Joins $9T Russell 2000 Index Following Successful IPO - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	27 (M)
Shares Float	10 (M)
Held by Insiders	42.8 (%)
Held by Institutions	38.8 (%)
Shares Short	583 (K)
Shares Short P.Month	467 (K)

EPS	-1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.01
Profit Margin	-57.6 %
Operating Margin	-69.2 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	98.4 %
Gross Profit (p.s.)	1.25
Sales Per Share	1.68
EBITDA (p.s.)	-0.97
Qtrly Earnings Growth	0 %
Operating Cash Flow	-28 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-12.7
PEG Ratio	0
Price to Book value	3.13
Price to Sales	7.46
Price to Cash Flow	-12

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.